Vanguard Group
MJN

Vanguard Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Vanguard Group’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,206,341
Closed -$1.09B – 4102
2017
Q1 		$1.09B Buy
12,206,341
+266,416
+2% +$21.9M 0.06% 400
2016
Q4 		$845M Buy
11,939,925
+193,362
+2% +$14.4M 0.05% 464
2016
Q3 		$928M Buy
11,746,563
+198,680
+2% +$16.9M 0.05% 417
2016
Q2 		$1.05B Buy
11,547,883
+154,730
+1% +$13.1M 0.07% 339
2016
Q1 		$968M Sell
11,393,153
-219,153
-2% -$16.3M 0.06% 352
2015
Q4 		$917M Buy
11,612,306
+82,099
+0.7% +$6.47M 0.06% 351
2015
Q3 		$812M Buy
11,530,207
+158,409
+1% +$13M 0.06% 377
2015
Q2 		$1.03B Buy
11,371,798
+134,542
+1% +$13M 0.07% 311
2015
Q1 		$1.13B Buy
11,237,256
+414,362
+4% +$41.8M 0.08% 283
2014
Q4 		$1.09B Buy
10,822,894
+370,113
+4% +$36.9M 0.08% 276
2014
Q3 		$1.01B Buy
10,452,781
+218,693
+2% +$20.7M 0.08% 271
2014
Q2 		$954M Buy
10,234,088
+219,320
+2% +$19.2M 0.08% 289
2014
Q1 		$833M Buy
10,014,768
+209,410
+2% +$17M 0.07% 305
2013
Q4 		$821M Buy
9,805,358
+126,052
+1% +$10.3M 0.07% 292
2013
Q3 		$719M Buy
9,679,306
+155,920
+2% +$11.7M 0.07% 305
2013
Q2 		$755M Buy
+9,523,386
New +$764M 0.08% 269

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Vanguard Group's MJN Position: Q2 2017 in Review

Vanguard Group sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 12,206,341 shares — an estimated $1.09B sold.

Vanguard Group first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $1.13B in Q1 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Vanguard Group reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Vanguard Group sold 12,206,341 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.09B.
  • Vanguard Group first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Vanguard Group's Mead Johnson Nutrition Company position peaked at $1.13B in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Vanguard Group's 13F filing for Q2 2017, filed 11 Aug 2017.